← Back to All Filings

ResMed Officer Files Intent to Sell $12k in Stock (RMD)

Low SignificanceDecember 1, 2025 at 12:32:37 PM EST

RESMED INC

$RMD144CIK: 0000943819

Subscribe to track RMD

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

ResMed Officer Files Intent to Sell $12k in Stock (RMD)

Company: RESMED INC (RMD) Form: 144 | Filed: 2025-12-01 Significance: Low

Insider: Rider Michael J Title: Officer | Relationship: Officer

Transaction: • Type: Proposed Sale • Shares: 50 • Price: ~$244.16 • Value: $12,208 • Owned After: Not Disclosed

Key Insight: An officer filed a notice for a de minimis sale of stock, likely part of a pre-arranged 10b5-1 trading plan established in February 2025.

Market Context: The transaction is negligible, representing less than 0.0001% of the company's market cap. This is a routine sale with no expected market impact.

Comprehensive Analysis

SEC Filing Analysis: RESMED INC (RMD)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer of ResMed has filed a notice of a proposed de minimis sale of 50 shares, valued at approximately $12,208.
  • Market Impact: The transaction is too small to have any market impact and is likely for personal financial management.

Company Information

FieldValue
CompanyRESMED INC
Ticker SymbolRMD
CIK0000943819
IndustrySurgical & Medical Instruments & Apparatus

Insider Information

FieldValue
NameRider Michael J
CIK0001982205
Title/PositionOfficer
RelationshipOfficer

Transaction Details

FieldValue
Form Type144
Transaction Date2025-12-01 (Approximate)
Transaction CodeS (Proposed Sale)
Security TypeCommon Stock
Shares Involved50
Price Per Share$244.16
Total Value$12,208.00
Shares Owned AfterNot Disclosed
Ownership TypeNot Disclosed

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$12,208.00
% of Market Cap0.000034%
Shares Transacted50
% of Shares Outstanding0.000034%
Post-Transaction OwnershipNot Disclosed
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a large-cap company with a market capitalization of $35.68 billion, this $12k transaction is entirely immaterial.
  • Transaction Significance: The sale represents a negligible fraction of both the company's market value and its outstanding shares, indicating it is a routine transaction with no strategic implications.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction's value is far too small to influence investor sentiment or stock price. It is a non-event from a market perspective.

Volume & Sentiment

  • Expected Volume Impact: None. The share amount is insignificant compared to daily trading volume.
  • Sentiment Indicator: Neutral. The filing does not provide any signal regarding the insider's outlook on the company.

Additional Context

Transaction Notes

  • Special Circumstances: The filing notes a plan adoption date of February 28, 2025, which strongly suggests this sale is being conducted under a pre-scheduled Rule 10b5-1 trading plan. This further reduces its significance as an indicator of current insider sentiment.
  • Transaction History: The insider also sold 100 shares on October 1, 2025, reinforcing the pattern of small, periodic sales.
Topics:#SECFiling#InsiderTrading#RMD#ResMed#Form144#InsiderSell#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.